Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor, Adult

Explore clinical trials studying Solid Tumor, Adult. Study availability and eligibility vary by location and protocol.

198 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor, Adult trial results

Completed

MGD019 DART® Protein in Unresectable/Metastatic Cancer

NCT03761017

Conditions
Advanced Cancer, Colonic Diseases, Colorectal Cancer, +24 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Completed

TCR-engineered T Cells in Solid Tumors: IMA202-101

NCT03441100

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
  • Universitätsklinikum Bonn - Medizinische Klinik III Bonn, North Rhine-Westphalia, Germany
View Trial Details
Completed

A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib

NCT04814667

Conditions
Locally Advanced Solid Tumor, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • CHU Amiens Amiens, France
  • Centre Georges Francois Leclerc Dijon, France
  • Centre Leon Berard Lyon, France
  • Chi Elbeuf Louviers Saint-Aubin-lès-Elbeuf, France
View Trial Details
Completed

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

NCT04020185

Conditions
Solid Tumor, Adult
Locations
  • Honor Health Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Atlantic Health System/Morristown Medical Center Morristown, New Jersey, United States
View Trial Details
Completed

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

NCT03922204

Conditions
Advanced Cancer, B-cell Lymphoma, Adult, Hemic and Lymphatic Diseases, +10 more
Locations
  • Moores Cancer Centre La Jolla, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospital Antwerp Antwerp, Edegem, Belgium
View Trial Details
Completed

A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

NCT04474470

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colorectal Adenocarcinoma, +14 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSD Moores Cancer Center San Diego, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Completed

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

NCT03873883

Conditions
Neoplasms, Solid Tumor, Adult
Locations
  • Karmanos Cancer Institute Michigan Center, Michigan, United States
  • John Theurer Cancer Center, Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • Hospital GZA Sint-Augustinus Wilrijk, Antwerpen, Belgium
View all 19 locations
View Trial Details

Related conditions